Fabasoft AG (FAA)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 16.05 |
|---|---|
| 52-week range | 10.30 – 17.95 |
| Return, 1 month / 3 months | −1.2% / +20.7% |
| Return, 1 year / 3 years | +5.3% / −5.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 49 |
| Volatility (1 year) | 37.0% |
| Worst drawdown (1 year) | -37.4% |
| Average daily value traded | 0.15M EUR |
| Dividend yield | 3.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Fabasoft AG is a software company based in Austria that develops enterprise content management and document management software. Its products help organisations capture, organise and archive documents and business records, and support electronic workflows and collaboration. Customers include public administration bodies, healthcare organisations and private companies, particularly in German-speaking Europe. The company also offers cloud-based services for managing digital files and processes.
Fabasoft AG trades under the code FAA on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Fabasoft AG (FAA) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 16.05 on 23 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 170 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.3% and over the last three months it rose 20.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 87 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 19.0% | ||
| From 52-week high | -7.0% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 20.7% | ||
| 6-month return | 39.2% | ||
| 12-month return, skipping the last month | 6.6% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.4% | ||
| Liquidity | 49 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.15M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.1% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.6% |
|---|---|
| 1 month | −1.2% |
| 3 months | +20.7% |
| 6 months | +39.2% |
| 1 year | +5.3% |
| 3 years | −5.5% |
| 5 years | −46.6% |
Signals
| 50-day / 200-day average | 16.17 / 13.48 |
|---|---|
| Golden / death cross (60 days) | Golden, 55 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Jul 2026 | EUR 0.5000 |
| 14 Jul 2025 | EUR 0.1000 |
| 5 Jul 2024 | EUR 0.1000 |
| 6 Jul 2023 | EUR 0.3000 |
| 4 Jul 2023 | EUR 0.2613 |
| 7 Jul 2022 | EUR 0.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.